Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07852585

Comparison of Pregnancy Outcomes in Primigravida Receiving Low-Dose Aspirin for the Prevention of Preeclampsia.

Conditions: Preeclampsia

Sex: Female
Ages: 18 Years – 40 Years
Healthy volunteers: No
Phase: NA
Enrollment: 160
Sponsor: Muhammad Aamir Latif

Location: Bahawal Victoria Hospital/Quaid-e-Azam Medical College Bahawalpur Punjab Province

Summary

Local data on the effectiveness of low-dose aspirin in high-risk primigravida are limited. The present study was planned to compare pregnancy outcomes between high-risk primigravida receiving low-dose aspirin (75 mg/day) from 12 weeks of gestation and those not receiving aspirin.

Eligibility Criteria

Inclusion Criteria: * Primigravida women * High-risk pregnancy * Aged 18-40 years * Singleton pregnancy * Gestational age ≤12 weeks Exclusion Criteria: * Women with pre-existing chronic hypertension * Renal disease * Diabetes mellitus * Autoimmune disease * Bleeding disorders * Hypersensitivity to aspirin * History of peptic ulcer disease * Those using aspirin or other antiplatelet drugs

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07852585). StuddyBuddy aggregates publicly available trial information.